Pharmaceutical Teleconsultation in Adults With Asthma

NCT05055661 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 246

Last updated 2023-04-18

No results posted yet for this study

Summary

The investigators propose a pragmatic randomized clinical study, consisting of two groups, the control group with health education and the intervention group with teleconsultation. The research team comprises pharmacists, students, and professors who work in a pharmaceutical service of secondary health care linked to the public university. The investigators will conduct the study exclusively remotely, following the patients for six months. The research team will implement and structure an ambiance to adapt the face-to-face pharmaceutical consultation into the pharmaceutical teleconsultation. The evaluated outcomes, in both groups, will be the scores of the Asthma Control Test, the Asthma Quality of Life, and the hospitalization rate and admission to urgency/emergency services.

Conditions

Interventions

OTHER

Pharmaceutical Teleconsultation

The pharmacist will apply the teleconsultation according to the elaborated workflows and will follow in seven steps: scheduling the teleconsultation; pre-consultation, in which the pharmacist will make a checklist of the adequacy of the teleconsultation environment; presentation of the professional and the objectives of the teleconsultation to the patient; search for information about the patient and their pharmacotherapy; identification of problems related to pharmacotherapy; elaboration of a care plan and appointment for the re-consultation.

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil

    collaborator OTHER
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

    collaborator OTHER_GOV
  • Federal University of Rio Grande do Sul

    lead OTHER

Principal Investigators

  • Denise Bueno, PhD · Federal University of Rio Grande do Sul

  • Stella Pegoraro Alves Zarpelon, MSc · Federal University of Rio Grande do Sul

  • Diogo Pilger, PhD · Federal University of Rio Grande do Sul

  • Aline de Lima Nogare, MSc · Federal University of Rio Grande do Sul

  • Luiza Fedatto Vidal, BSc · Federal University of Rio Grande do Sul

  • Fernando Kreutz, PhD · Federal University of Rio Grande do Sul

  • Luciane Piva Klein, BSc · Federal University of Rio Grande do Sul

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2023-06-30
Completion
2024-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05055661 on ClinicalTrials.gov